- Home
- OMEX vs SNTI Comparison
OMEX vs SNTI Comparison
Compare OMEX & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMEX
- SNTI
- Stock Information
- Founded
- OMEX 1986
- SNTI 2016
- Country
- OMEX United States
- SNTI United States
- Employees
- OMEX N/A
- SNTI N/A
- Industry
- OMEX Marine Transportation
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- OMEX Consumer Discretionary
- SNTI Health Care
- Exchange
- OMEX Nasdaq
- SNTI Nasdaq
- Market Cap
- OMEX 44.8M
- SNTI 50.3M
- IPO Year
- OMEX N/A
- SNTI N/A
- Fundamental
- Price
- OMEX $1.41
- SNTI $1.68
- Analyst Decision
- OMEX
- SNTI Strong Buy
- Analyst Count
- OMEX 0
- SNTI 2
- Target Price
- OMEX N/A
- SNTI $8.50
- AVG Volume (30 Days)
- OMEX 2.9M
- SNTI 510.7K
- Earning Date
- OMEX 08-12-2025
- SNTI 08-12-2025
- Dividend Yield
- OMEX N/A
- SNTI N/A
- EPS Growth
- OMEX N/A
- SNTI N/A
- EPS
- OMEX 0.23
- SNTI N/A
- Revenue
- OMEX $700,613.00
- SNTI N/A
- Revenue This Year
- OMEX N/A
- SNTI N/A
- Revenue Next Year
- OMEX N/A
- SNTI $150.00
- P/E Ratio
- OMEX $5.67
- SNTI N/A
- Revenue Growth
- OMEX N/A
- SNTI N/A
- 52 Week Low
- OMEX $0.27
- SNTI $1.52
- 52 Week High
- OMEX $5.25
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- OMEX 50.30
- SNTI 29.38
- Support Level
- OMEX $1.55
- SNTI $1.86
- Resistance Level
- OMEX $1.79
- SNTI $2.12
- Average True Range (ATR)
- OMEX 0.20
- SNTI 0.14
- MACD
- OMEX -0.04
- SNTI -0.00
- Stochastic Oscillator
- OMEX 29.63
- SNTI 12.00
About OMEX Odyssey Marine Exploration Inc.
Odyssey Marine Exploration Inc is a deep-ocean exploration company. The company provides specialized mineral exploration, project development, and marine services to clients. It is engaged in the discovery, validation, and development of subsea mineral deposits in a socially and environmentally responsible manner. The company works with governments to identify mineral resources in Exclusive Economic Zones, focusing on phosphorite (fertilizer) and polymetallic nodules (battery metals) projects. Its projects include the ExO Phosphate project, CIC, Ocean Minerals, and the LIHIR Gold project.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.